Alkem Laboratories Profit & Loss Annual

Trade
BSE: 539523 | NSE: ALKEM | ISIN: INE540L01014 | Sector: Biotechnology & Drugs
5,470.85 -101.10 (-1.81%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 12,667.5811,599.2610,634.198,865.01
Total Revenue 12,667.5811,599.2610,634.198,865.01
Costof Revenue Total 4,937.584,930.444,263.823,589.11
Gross Profit 7,730.006,668.826,370.375,275.90
Selling/ General/ Admin Expenses Total 2,201.014,877.774,240.273,277.01
Depreciation/ Amortization 299.30310.42303.96274.58
Other Operating Expenses Total 3,283.5096.3353.5154.83
Total Operating Expense 10,721.3910,320.118,862.687,195.53
Operating Income 1,946.191,279.151,771.511,669.48
Interest Inc( Exp) Net- Non- Op Total -2,339.00503.40671.601,358.40
Other Net 310.84-12.363.64-2.02
Net Income Before Taxes 2,023.131,304.771,844.281,842.10
Provisionfor Income Taxes 211.67297.96163.96224.33
Net Income After Taxes 1,811.461,006.811,680.321,617.77
Minority Interest -15.69-22.64-34.70-32.75
Net Income Before Extra Items 1,795.77984.171,645.621,585.02
Net Income 1,795.77984.171,645.621,585.02
Income Availableto Com Excl Extra Ord 1,795.77984.171,645.621,585.02
Income Availableto Com Incl Extra Ord 1,795.77984.171,645.621,585.02
Diluted Net Income 1,795.77984.171,645.621,585.02
Diluted Weighted Average Shares 11.9611.9611.9611.96
Diluted EPS Excluding Extra Ord Items 150.1982.31137.63132.57
DPS- Common Stock Primary Issue 40.0025.0034.0030.00
Diluted Normalized EPS 150.1989.90137.57129.72
Unusual Expense( Income) -105.151.120.00
Gain( Loss)on Saleof Assets --123.6019.70388.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts